<DOC>
	<DOCNO>NCT01598623</DOCNO>
	<brief_summary>The objective study : 1 . To evaluate effect OT compare placebo , add-on anti-psychotics , social functioning schizophrenia . 2 . To evaluate effect socially orient CBT administer patient immediately receive OT , compare patient receive OT not-socially orient CBT , compare patient receive socially orient CBT without OT . The investigator hypothesize OT socially orient CBT synergistic effect , good OT CBT alone . 3 . Use detail , depth analysis social interaction assess putative effect OT . The investigator hypothesize use analysis show large treatment effect OT previously show less sensitive assessment , PANSS . 4 . To assess effect epigenetic status response OT . The investigator hypothesize epigenetic variant associate low OT plasma level associate great response OT treatment . 5 . To assess relationship level salivary OT vasopressin , social interaction schizophrenia . 6 . To assess relationship level salivary OT vasopressin , response OT treatment .</brief_summary>
	<brief_title>Administrating Oxytocin Treat Treatment Schizophrenia Schizo-affective Patients</brief_title>
	<detailed_description>Social disability hallmark schizophrenia , improve social functioning schizophrenia improve patient ' overall functioning quality life . Oxytocin ( Granholm , McQuaid et al . ) nine amino-acid neuropeptide synthesize hypothalamus , find modulate social behavior mammal , include human ( Insel Young 2001 ; Kosfeld , Heinrichs et al . 2005 ) . Among influence human social behavior increase trust ( Kosfeld , Heinrichs et al . 2005 ) , empathy ( Hurlemann , Patin et al . 2010 ) eye contact ( Guastella , Mitchell et al . 2008 ) . Impaired social behavior core domain Autism Spectrum Disorders ( ASD ) ( Modahl , Green et al . 1998 ; Bartz Hollander 2008 ) ; study show social disability associate OT dysfunction ASD , improve administration intranasal OT ( Hollander , Bartz et al . 2007 ; Andari , Duhamel et al . 2010 ; Guastella , Einfeld et al . 2010 ) . Furthermore , epigenetic change gene encode OT demonstrate autism ( Gregory , Connelly et al . 2009 ) Impaired social functioning hallmark schizophrenia ; study show plasma level endogenous OT low schizophrenia patient compare control , patient low level plasma OT positive symptom ( Kéri , Kiss et al . 2009 ; Kיri , Kiss et al . 2009 ; Rubin , Carter et al . 2010 ) . Moreover , recent study demonstrate significant genetic association OT Arginine Vasopressin , another peptide link social behavior , schizophrenia ( Teltsh , Kanyas-Sarner et al . 2011 ) . Only two publish study investigate therapeutic potential OT schizophrenia ; administer OT addition anti-psychotic treatment . Feifel ( Feifel , Macdonald et al . 2010 ) report decrease positive symptom 3 week treatment , Pedersen ( Pedersen , Gibson et al . 2011 ) report improvement social cognition . There ongoing research aim validate finding . Vasopressin also peptide putative effect social interaction ( Ebstein , Israel et al . 2009 ; Heinrichs , von Dawans et al . 2009 ) . In propose study assay salivary level OT vasopressin . In propose study intend administer OT placebo-controlled , double-blind design patient schizophrenia . In addition assess effect OT symptom schizophrenia , proposal four characteristic believe unique , hope enable large step forward understanding role OT schizophrenia . - Social functioning : assess use previously validate technique , video-taping interview schizophrenia patient . The quality social interaction assess , raters blind treatment status . The assessment , specifically focus gaze experimenter 's face , vocalization ( patient 's vocal output , positive/negative tone , fluent speech ) affect , body tone , movement , non-verbal sign . This technique develop Prof. Feldman 's lab , show accurately assess social interaction ( Feldman , Masalha et al . 2001 ; Feldman Klein 2003 ; Feldman Eidelman 2009 ; Feldman 2010 ) . This technique enable meticulous quantification putative effect OT social functioning schizophrenia . - Data preclinical model traumatic brain injury ( Feeney , Gonzalez et al . 1982 ) clinical study stroke patient ( Crisostomo , Duncan et al . 1988 ; Scheidtmann , Fries et al . 2001 ; Taub , Uswatte et al . 2002 ) ] suggest new learn develops faster , increase magnitude longer lasting combine intervention drug practice relative learn occur either intervention isolation . Similar thought express regard compound putatively enhance cognition , patient receive compound enhance cognition treat cognitive remediation time . We propose apply concept OT . In proposal , patient treat cognitive-behavioral therapy ( socially orient CBT ) focus social interaction , emphasize eye contact , body language , empathy , etc . Socially orient CBT administer three times/week time period immediately OT administration , OT active . There control CBT condition address medication compliance vocational rehabilitation , without social orientation , somewhat analogous demand characteristic . We hypothesize combined effect OT co-administered socially orient CBT synergistic , i.e . great effect either alone . - The effect epigenetic variation effect OT treatment examine assess epigenetic status subject , correlate response treatment . We examine methylation status two CpG site ( -934 -924 ) OXTR promoter . The epigenetic evaluation would detect whether exogenously administer OT change OXTR gene , expression function OT level behavior . - Two previous study administer 40 international unit ( IU ) X2/d= 80 IU/d ( Feifel , Macdonald et al . 2010 ) 24 IU X2/d= 48 IU/d ( Pedersen , Gibson et al . 2011 ) , adverse effect . Based data , propose administer 24 IU X3/d= 72 IU . This dose low Feifel et al . adverse effect see . Therefore , sure thus dose safe .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1 . Male female , 1865 year age , inclusive 2 . Females abstinent practice establish method birth control ( oral contraceptive tablet , hormonal implant device , hormone patch , injectable contraceptive , intrauterine device [ IUD ] ) . 3 . Willing able provide inform consent , nature study fully explain 4 . Current DSMIVTR diagnosis schizophrenia schizoaffective disorder confirm modified SCID . 5 . Symptoms : PANSS total score ≤75 6 . A score 4 ( moderate ) high least one , follow PANSS negative item : emotional withdrawal , poor rapport , passiveapathetic social withdrawal 7 . Receiving antipsychotic medication 2 week randomization . 8 . Inpatients outpatient . Inpatients randomize 3 day admission , provide medication change since hospitalization . 9 . Adjunctive treatment anticholinergic agent , betablockers , mood stabilizer , antidepressant ; anxiolytic allow provided patient medication least 2 week prior entry screen phase study . 1 . Unwilling unable , opinion Investigator , comply study instruction . 2 . Pregnant breastfeeding . 3 . Clinically significant medical disease ( malignancy , poorly control diabetes , active ischemic cardiac disease , cardiomyopathy , serious pulmonary disease , kidney disease , impair liver function ) . 4 . At significant risk commit suicide , opinion Investigator , currently imminent risk suicide harm others . 5 . Patients current DSMIV substance alcohol abuse . Patients history and/or current recreational use cannabinoids alcohol , and/or patient smoke cigarette include . 6 . Concurrent delirium , mental retardation , druginduced psychosis , history clinically significant brain trauma document CT MRI . 7 . Patients significantly impair renal liver function , define GOP GPT level &gt; 3 time high normal value , blood creatinine level 1.5 exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>